Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
19 studies found for:    " July 25, 2007":" August 24, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" July 25, 2007":" August 24, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (19 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection
Condition: HIV Infections
Interventions: Other: Behavioral counseling;   Device: HIV-1 Antibody Test Kit
2 Completed Integrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK0518);   Drug: Placebo;   Procedure: Leukopheresis;   Procedure: Sigmoid Biopsy
3 Completed Kaletra Monotherapy in HIV/HCV Co-infected Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra Tablets
4 Unknown  Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
5 Unknown  Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
Conditions: HIV Infections;   Cancer, Second Primary
Interventions: Dietary Supplement: Probiotic Yogurt B: with various micronutrients;   Dietary Supplement: Probiotic Yogurt A: Kaiser micronutrients;   Dietary Supplement: Probiotic yogurt C: with basic micronutrients;   Dietary Supplement: Probiotic Yogurt D: Placebo -- no added micronutrients
6 Completed Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Condition: HIV Infections
Interventions: Drug: matching placebo;   Drug: Bevirimat
7 Terminated TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Condition: HIV Infections
Intervention: Drug: TMC114 (darunavir) / ritonavir
8 Completed Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy
Condition: HIV Infections
Intervention:
9 Completed Autologous Dendritic Cell Vaccine in HIV1 Infection
Condition: HIV Infections
Intervention: Biological: Autologous HIV-1 ApB DC Vaccine
10 Completed DDI HV (ATV - Merck)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Drug: Atazanavir + Raltegravir
11 Terminated Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy
Conditions: Depression;   HIV Infection
Intervention: Behavioral: Cognitive behavioral therapy (CBT)
12 Completed
Has Results
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518);   Drug: Placebo
13 Completed Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
Condition: HIV Infections
Intervention: Drug: Pyridostigmine tablets
14 Recruiting Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections
Intervention:
15 Terminated
Has Results
Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Darunavir;   Drug: Ritonavir
16 Completed Intervention for Newly Diagnosed Youth With HIV
Condition: HIV
Intervention: Behavioral: "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
17 Completed Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
Condition: HIV
Intervention:
18 Unknown  Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neurotoxicity;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: baclofen/amitriptyline/ketamine gel;   Other: placebo
19 Completed Lufwanyama Neonatal Survival Project
Condition: Mortality
Interventions: Other: Neonatal resuscitation protocol;   Other: Standard of care

Indicates status has not been verified in more than two years